You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SCTX Award Disclosure
Lucas Svetlana · SEC Form 4 · Filed Jul 27, 2026
Award
Calculated transaction value
$0
Lucas Svetlana Chief Business Officer
SCTX
Transaction date
Mar 13, 2026
Public filing date
Jul 27, 2026
Filing lag
Filed 136 days later
SCTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 9,547 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001781292-26-000007
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$45K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Scribe Therapeutics, Inc. SCTX | Award | Jul 23, 2026 | $0 |
| Scribe Therapeutics, Inc. SCTX | Buy | Jul 23, 2026 | $45K |
| Scribe Therapeutics, Inc. SCTX | Award | Jul 23, 2026 | $0 |
| Scribe Therapeutics, Inc. SCTX Current | Award | Mar 13, 2026 | $0 |